| Gender Preference | None |
| Age Group | 15 - 99 years |
| Research Start Date | August 31, 2012 |
| Research End Date | February 28, 2013 |
| Principal Investigator | Andrea Swenson, MD |
| Description |
- Purpose: to find out if methotrexate is an effective therapy for MG and if it will allow patients with MG to use less prednisone.
- Eligibility: patients ages 15 and older with MG who are on a stable dose of Prednisone 10 mg per day or greater.
- Duration and Involvement: patients will take study medication (methotrexate 20 mg vs. placebo) by mouth once weekly and return to clinic once per month for approximately 14 months.
|
| Contact Info | Jeri Sieren, RN at 319-356-8744 |
| Keywords | span itemProp='description'>Methotrexate ; Neurology ; |